Table 3

Comparison of mortality rates between the Parkinson’s disease and control patient groups according to the cause of death

Cause of deathTotal participants
Parkinson’s disease (total n=3510)Control (total n=14 040)OR (95% CI)P-value
No of died individual*No of died individual*
All of death1214 (34.6)100.02661 (19.0)100.02.26 (2.08 to 2.45)<0.001‡
Infection23 (0.7)1.974 (0.5)2.81.25 (0.78 to 1.99)0.375
Neoplasm151 (4.3)12.4667 (4.8)25.10.90 (0.75 to 1.08)0.283
Metabolic disease76 (2.2)6.2161 (1.1)6.11.91 (1.45 to 2.51)<0.001‡
Mental diseases33 (0.9)2.749 (0.3)1.82.71 (1.74 to 4.22)<0.001‡
Neurologic disease328 (9.3)27.069 (0.5)2.620.87 (16.05 to 27.14)<0.001‡
Circulatory disease277 (7.9)22.8705 (5.0)26.51.62 (1.40 to 1.87)<0.001‡
Respiratory disease97 (2.8)8.0248 (1.8)9.31.58 (1.25 to 2.01)<0.001‡
Digestive disease30 (0.9)2.588 (0.6)3.31.37 (0.90 to 2.07)0.139
Muscular disease8 (0.2)0.715 (0.1)0.62.14 (0.91 to 5.04)0.076
Genitourinary disease25 (0.7)2.150 (0.4)1.92.01 (1.24 to 3.25)0.004‡
Trauma64 (1.8)5.3154 (1.1)5.81.68 (1.25 to 2.25)0.001‡
Others102 (2.9)8.4381 (2.7)14.31.07 (0.86 to 1.34)0.533
  • *Calculated as the proportion of the number of deaths among all participants with/without mortality.

  • †Calculated as the proportion of the number of deaths among participants with mortality.

  • ‡χ2 test or Fisher’s exact test. Significance at false discovery rate-adjusted p<0.05.